Search

everythinglearnresearchcommunity

for

Search:↓

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Puerto Rican children with cancer often experience symptoms like irritability, nausea, and hair loss, and need better education and continuous symptom management.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Zebrafish larvae are used to study and find treatments for ear cell damage because they are easier to observe and test than mammals.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Chemotherapy in children often causes hair loss, nausea, vomiting, and mood swings.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Semecarpus anacardium leaf extract fights breast cancer and extends survival in mice.

Activin A increases inner ear hair cell development, while follistatin decreases it.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Scalp cooling reduces chemotherapy-induced hair loss without increasing risk of skin metastases.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.